NeXT Dx Personalis, Inc.
United States | 1 | 413 | - I Microsatellite instability testing (MSI)
- R RNA analysis
- C Sequence analysis of the entire coding region
|
Tempus xT Tempus AI - RTP
United States | 2 | 647 | - I Microsatellite instability testing (MSI)
- C Sequence analysis of the entire coding region
|
Hereditary Cancer Screening - Full Hereditary Cancer Panel (99 Genes) Genesys Diagnostics Genesys Diagnostics, Inc.
United States | 109 | 99 | - X Mutation scanning of select exons
|
ERCC5 Gene Xeroderma pigmentosum, group G NGS Genetic DNA Test DNA Labs India
India | 1 | 1 | - S Mutation scanning of the entire coding region
|
Tempus xT Tempus AI - CHI
United States | 2 | 647 | - I Microsatellite instability testing (MSI)
- C Sequence analysis of the entire coding region
|
ERCC5 - NGS including CNV analysis Centogene AG - the Rare Disease Company
Germany | 2 | 1 | - D Deletion/duplication analysis
- C Sequence analysis of the entire coding region
|
CentoNeuro Panel Centogene AG - the Rare Disease Company
Germany | 1886 | 1858 | - D Deletion/duplication analysis
- C Sequence analysis of the entire coding region
|
CentoVision Panel Centogene AG - the Rare Disease Company
Germany | 417 | 413 | - D Deletion/duplication analysis
- C Sequence analysis of the entire coding region
|
Neuromuscular Panel Centogene AG - the Rare Disease Company
Germany | 325 | 316 | - D Deletion/duplication analysis
- X Mutation scanning of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
CentoDysmorph Panel Centogene AG - the Rare Disease Company
Germany | 740 | 728 | - D Deletion/duplication analysis
- C Sequence analysis of the entire coding region
|
MayoComplete Solid Tumor Panel Mayo Clinic Laboratories Mayo Clinic
United States | 1 | 476 | - I Microsatellite instability testing (MSI)
- R RNA analysis
- C Sequence analysis of the entire coding region
|
JAX SOMASEQ The Jackson Laboratory for Genomic Medicine
United States | 1 | 517 | - D Deletion/duplication analysis
- I Microsatellite instability testing (MSI)
- R RNA analysis
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Endeavor PathGroup
United States | 73 | 505 | - C Sequence analysis of the entire coding region
|
OmniSeq INSIGHT OmniSeq, Inc.
United States | 1 | 525 | - R RNA analysis
- C Sequence analysis of the entire coding region
|
Cerebrooculofacioskeletal syndrome 3, 616570, Autosomal recessive; COFS3 (COFS) (ERCC5 gene) (Sequence Analysis-All Coding Exons) (Prenatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey | 1 | 1 | - C Sequence analysis of the entire coding region
|
Cerebrooculofacioskeletal syndrome 3, 616570, Autosomal recessive; COFS3 (COFS) (ERCC5 gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey | 1 | 1 | - C Sequence analysis of the entire coding region
|
Xeroderma pigmentosum, group G/Cockayne syndrome, 278780, Autosomal recessive (Xeroderma pigmentosum) (ERCC5 gene) (Sequence Analysis-All Coding Exons) (Prenatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey | 1 | 1 | - C Sequence analysis of the entire coding region
|
Xeroderma pigmentosum, group G, 278780, Autosomal recessive (Xeroderma pigmentosum) (ERCC5 gene) (Sequence Analysis-All Coding Exons) (Prenatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey | 1 | 1 | - C Sequence analysis of the entire coding region
|
Xeroderma pigmentosum, group G, 278780, Autosomal recessive (Xeroderma pigmentosum) (ERCC5 gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey | 1 | 1 | - C Sequence analysis of the entire coding region
|
Xeroderma pigmentosum, group G/Cockayne syndrome, 278780, Autosomal recessive (Xeroderma pigmentosum) (ERCC5 gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey | 1 | 1 | - C Sequence analysis of the entire coding region
|
